tiprankstipranks
Trending News
More News >
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Similar Stocks

Compare
581 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$36.83
$2.91B
-12.45
211.33%
6 Buy
0 Hold
0 Sell
Strong Buy
Viking Therapeutics
$35.19
$3.98B
-16.61
-15.18%
13 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$44.10
$3.41B
-11.35
13.37%
15 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$24.65
$3.12B
83.02
-25.78%
9 Buy
6 Hold
1 Sell
Moderate Buy
NewAmsterdam Pharma Company
$35.11
$3.98B
-17.19
37.90%
8 Buy
1 Hold
0 Sell
Strong Buy
Centessa Pharmaceuticals
$24.85
$3.34B
-13.65
41.60%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLYS
Mineralys Therapeutics, Inc.
36.83
24.49
198.46%
VKTX
Viking Therapeutics
35.19
-7.06
-16.71%
XENE
Xenon
44.10
5.47
14.16%
APLS
Apellis Pharmaceuticals
24.65
-8.56
-25.78%
NAMS
NewAmsterdam Pharma Company
35.11
9.61
37.69%
CNTA
Centessa Pharmaceuticals
24.85
7.69
44.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts